Shryock Christopher P 4

What Happened

• Christopher P. Shryock, Chief Human Resources Officer of Medline (MDLN), received equity awards reported on a Form 4 filed March 6, 2026. The filing shows grants totaling 548,590 units: 11,903 restricted stock units (RSUs) (acquired 2026-03-05 at $0.00) and two derivative incentive-unit grants of 496,049 and 40,638 units (recorded 2025-12-16; reported as derivative acquisitions with no per-share price).
• The derivative awards are “Incentive Units” (profit-interest style units) that can convert into common units and, under an exchange agreement, into Class A common stock. No cash purchase or sale occurred—these are awards/derivative grants, not open-market buys or sales.

Key Details

• Transaction dates/prices: 2026-03-05 — 11,903 RSUs @ $0.00 (acquired); 2025-12-16 — 496,049 and 40,638 incentive units (derivative acquisitions; price shown as N/A).
• Total units reported: 548,590 (11,903 RSUs + 536,687 incentive units).
• Shares owned after transaction: not specified in the provided filing excerpt; see full Form 4 for total holdings.
• Vesting and conversion notes:
  • RSUs (11,903): 25% vest June 15, 2026; remaining 75% vest in three equal annual installments beginning March 1, 2027. (Footnote F1)
  • Incentive Units: profit-interest style units convertible to common units, then exchangeable 1-for-1 for Class A shares per a Dec 16, 2025 exchange agreement; no expiration. (F2, F3)
  • One set of Incentive Units: 20% vested; remaining 80% vest in four equal annual installments beginning Sept 27, 2026. (F5)
  • Other Incentive Units: vest in five equal annual installments beginning March 28, 2026. (F6)
  • These derivative interests were part of a pre-IPO reclassification previously reported on the insider’s Form 3 (filed Dec 17, 2025). (F4)
• Filing timeliness: Form 4 was filed March 6, 2026 for transactions dated Dec 16, 2025 and Mar 5, 2026 — this is later than the standard two-business-day Form 4 reporting window.

Context

• These entries reflect awards and convertible/derivative interests, not purchases or sales. Incentive Units are tied to future value and conversion mechanics (they have characteristics like stock appreciation rights) and will only translate into publicly traded Class A shares under the conversion/exchange rules described in the footnotes.
• For retail investors: awards/vesting schedules indicate potential future dilution and alignment of executive compensation with stock performance, but they do not by themselves indicate immediate buying or selling by the insider.